DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Xu B, Yan M, Ma F. et al.
Pyrotinib or lapatinib plus capecitabine for HER2+ metastatic breast cancer (PHOEBE): A randomized phase III trial.
J Clin Oncol 2020;
38: 1003-1003
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.